Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-10-010247
Filing Date
2010-06-10
Accepted
2010-06-10 16:33:55
Documents
1
Period of Report
2010-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 6652
  Complete submission text file 0001179110-10-010247.txt   8229
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAXTON ASSOCIATES 500 PARK AVENUE NEW YORK NY 10022
Business Address
Kovner Bruce (Reporting) CIK: 0001325713 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 10890685